Humana Inc. (HUM)

$311.41

-4.57

(-1.45%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Humana Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 26.42B → 29.61B (in $), with an average increase of 5.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -541.0M → 741.0M (in $), with an average increase of 173.0% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 42.8% return, outperforming this stock by 81.2%

  • Vs ELV

    In the last 3 years, Elevance Health, Inc has given 42.2% return, outperforming this stock by 72.4%

Performance

  • $308.45
    $315.39
    $311.41
    downward going graph

    0.95%

    Downside

    Day's Volatility :2.2%

    Upside

    1.26%

    downward going graph
  • $299.23
    $536.74
    $311.41
    downward going graph

    3.91%

    Downside

    52 Weeks Volatility :44.25%

    Upside

    41.98%

    downward going graph

Returns

PeriodHumana Inc.Sector (Health Care)S&P500
3 Months
-13.79%
0.5%
3.2%
6 Months
-39.34%
11.7%
22.0%
1 Year
-38.39%
6.2%
24.5%
3 Years
-30.2%
13.5%
20.6%

Highlights

Market Capitalization
39.5B
Book Value
$133.05
Dividend Share
3.54
Dividend Yield
1.08%
Earnings Per Share (EPS)
20.01
PE Ratio
15.79
PEG Ratio
1.64
Wall Street Target Price
378.78
Profit Margin
2.34%
Operating Margin TTM
0.21%
Return On Assets TTM
6.34%
Return On Equity TTM
15.68%
Revenue TTM
106.4B
Revenue Per Share TTM
858.78
Quarterly Revenue Growth YOY
17.9%
Gross Profit TTM
17.2B
EBITDA
4.9B
Diluted Eps TTM
20.01
Quarterly Earnings Growth YOY
-0.28
EPS Estimate Current Year
16.36
EPS Estimate Next Year
22.9
EPS Estimate Current Quarter
6.12
EPS Estimate Next Quarter
5.81

Analyst Recommendation

Buy
    72%Buy
    28%Hold
    0
    0%Sell
Based on 25 Wall street analysts offering stock ratings for Humana Inc.(by analysts ranked 0 to 5 stars)
Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
20
21
Hold
7
7
8
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 21.63%

Current $311.41
Target $378.78

Company Financials

FY18Y/Y Change
Revenue
56.9B
↑ 5.85%
Net Income
1.7B
↓ 31.25%
Net Profit Margin
2.96%
↓ 1.59%
FY19Y/Y Change
Revenue
64.9B
↑ 14.01%
Net Income
2.7B
↑ 60.84%
Net Profit Margin
4.17%
↑ 1.21%
FY20Y/Y Change
Revenue
77.2B
↑ 18.9%
Net Income
3.4B
↑ 24.38%
Net Profit Margin
4.36%
↑ 0.19%
FY21Y/Y Change
Revenue
83.1B
↑ 7.66%
Net Income
2.9B
↓ 12.89%
Net Profit Margin
3.53%
↓ 0.83%
FY22Y/Y Change
Revenue
92.9B
↑ 11.81%
Net Income
2.8B
↓ 4.33%
Net Profit Margin
3.02%
↓ 0.51%
FY23Y/Y Change
Revenue
106.4B
↑ 14.61%
Net Income
2.5B
↓ 11.3%
Net Profit Margin
2.34%
↓ 0.68%
Q4 FY22Q/Q Change
Revenue
22.4B
↓ 1.58%
Net Income
-15.0M
↓ 101.26%
Net Profit Margin
-0.07%
↓ 5.3%
Q1 FY23Q/Q Change
Revenue
26.7B
↑ 19.18%
Net Income
1.2B
↓ 8360.0%
Net Profit Margin
4.63%
↑ 4.7%
Q2 FY23Q/Q Change
Revenue
26.7B
↑ 0.02%
Net Income
959.0M
↓ 22.6%
Net Profit Margin
3.59%
↓ 1.04%
Q3 FY23Q/Q Change
Revenue
26.4B
↓ 1.21%
Net Income
832.0M
↓ 13.24%
Net Profit Margin
3.15%
↓ 0.44%
Q4 FY23Q/Q Change
Revenue
26.5B
↑ 0.15%
Net Income
-541.0M
↓ 165.02%
Net Profit Margin
-2.04%
↓ 5.19%
Q1 FY24Q/Q Change
Revenue
29.6B
↑ 11.9%
Net Income
741.0M
↓ 236.97%
Net Profit Margin
2.5%
↑ 4.54%
FY18Y/Y Change
Total Assets
25.4B
↓ 6.49%
Total Liabilities
15.3B
↓ 12.02%
FY19Y/Y Change
Total Assets
29.1B
↑ 14.41%
Total Liabilities
17.0B
↑ 11.7%
FY20Y/Y Change
Total Assets
35.0B
↑ 20.28%
Total Liabilities
21.2B
↑ 24.68%
FY21Y/Y Change
Total Assets
44.3B
↑ 26.81%
Total Liabilities
28.2B
↑ 32.95%
FY22Y/Y Change
Total Assets
43.1B
↓ 2.9%
Total Liabilities
27.7B
↓ 1.97%
FY23Y/Y Change
Total Assets
46.9B
↑ 8.91%
Total Liabilities
30.6B
↑ 10.44%
Q4 FY22Q/Q Change
Total Assets
43.1B
↓ 15.19%
Total Liabilities
27.7B
↓ 19.63%
Q1 FY23Q/Q Change
Total Assets
54.8B
↑ 27.22%
Total Liabilities
38.1B
↑ 37.77%
Q2 FY23Q/Q Change
Total Assets
56.5B
↑ 3.07%
Total Liabilities
39.6B
↑ 3.73%
Q3 FY23Q/Q Change
Total Assets
55.9B
↓ 0.97%
Total Liabilities
38.9B
↓ 1.68%
Q4 FY23Q/Q Change
Total Assets
46.9B
↓ 16.12%
Total Liabilities
30.6B
↓ 21.41%
Q1 FY24Q/Q Change
Total Assets
50.1B
↑ 6.82%
Total Liabilities
33.9B
↑ 10.89%
FY18Y/Y Change
Operating Cash Flow
2.2B
↓ 46.36%
Investing Cash Flow
-3.1B
↑ 4.96%
Financing Cash Flow
-785.0M
↓ 16.93%
FY19Y/Y Change
Operating Cash Flow
5.3B
↑ 143.17%
Investing Cash Flow
-1.3B
↓ 58.6%
Financing Cash Flow
-2.3B
↑ 192.36%
FY20Y/Y Change
Operating Cash Flow
5.6B
↑ 6.72%
Investing Cash Flow
-3.1B
↑ 139.83%
Financing Cash Flow
-2.0B
↓ 14.81%
FY21Y/Y Change
Operating Cash Flow
2.3B
↓ 59.89%
Investing Cash Flow
-6.6B
↑ 113.9%
Financing Cash Flow
3.0B
↓ 254.22%
FY22Y/Y Change
Operating Cash Flow
4.6B
↑ 102.79%
Investing Cash Flow
-1.0B
↓ 84.66%
Financing Cash Flow
-1.9B
↓ 163.48%
Q4 FY22Q/Q Change
Operating Cash Flow
-5.1B
↓ 160.65%
Investing Cash Flow
-1.0B
↓ 160.02%
Financing Cash Flow
-2.4B
↑ 31.66%
Q1 FY23Q/Q Change
Operating Cash Flow
6.7B
↓ 230.43%
Investing Cash Flow
-1.3B
↑ 28.43%
Financing Cash Flow
3.3B
↓ 239.06%
Q2 FY23Q/Q Change
Operating Cash Flow
3.2B
↓ 52.5%
Investing Cash Flow
-733.0M
↓ 43.27%
Financing Cash Flow
36.0M
↓ 98.9%
Q3 FY23Q/Q Change
Operating Cash Flow
1.3B
↓ 60.58%
Investing Cash Flow
-2.6B
↑ 256.07%
Financing Cash Flow
-1.7B
↓ 4913.89%

Technicals Summary

Sell

Neutral

Buy

Humana Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Humana Inc.
Humana Inc.
-10.61%
-39.34%
-38.39%
-30.2%
20.7%
The Cigna Corp
The Cigna Corp
-0.9%
16.53%
42.85%
42.16%
120.27%
Centene Corp.
Centene Corp.
-2.42%
11.11%
13.58%
14.67%
43.8%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
0.31%
-6.53%
2.26%
24.76%
108.38%
Cvs Health Corporation
Cvs Health Corporation
-15.12%
-0.96%
-6.82%
-11.12%
25.78%
Elevance Health, Inc
Elevance Health, Inc
4.34%
19.98%
19.3%
42.96%
102.58%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Humana Inc.
Humana Inc.
15.79
15.79
1.64
16.36
0.16
0.06
0.01
133.05
The Cigna Corp
The Cigna Corp
20.25
20.25
0.89
28.43
0.12
0.04
0.02
158.03
Centene Corp.
Centene Corp.
15.39
15.39
0.68
6.77
0.11
0.04
NA
48.35
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
29.77
29.77
1.24
27.62
0.17
0.07
0.02
100.18
Cvs Health Corporation
Cvs Health Corporation
10.47
10.47
1.0
8.3
0.11
0.04
0.04
59.36
Elevance Health, Inc
Elevance Health, Inc
20.12
20.12
1.14
37.28
0.16
0.06
0.01
174.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Humana Inc.
Humana Inc.
Buy
$39.5B
20.7%
15.79
2.34%
The Cigna Corp
The Cigna Corp
Buy
$99.9B
120.27%
20.25
2.65%
Centene Corp.
Centene Corp.
Buy
$40.8B
43.8%
15.39
1.91%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$448.4B
108.38%
29.77
4.05%
Cvs Health Corporation
Cvs Health Corporation
Buy
$85.4B
25.78%
10.47
2.34%
Elevance Health, Inc
Elevance Health, Inc
Buy
$124.0B
102.58%
20.12
3.64%

Institutional Holdings

  • Vanguard Group Inc

    9.26%

  • BlackRock Inc

    8.99%

  • State Street Corporation

    4.83%

  • Wellington Management Company LLP

    4.45%

  • FMR Inc

    3.97%

  • T. Rowe Price Associates, Inc.

    3.23%

Corporate Announcements

  • Humana Inc. Dividends March,2024

    In the quarter ending March,2024. Humana Inc. has declared dividend of $0.89

    Read More

Company Information

at humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it. our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.

Organization
Humana Inc.
Employees
67600
CEO
Mr. Bruce Dale Broussard
Industry
Health Services

Discover More

FAQs